| scholarly article | Q13442814 |
| P50 | author | Katherine H Parker | Q42360964 |
| P2093 | author name string | Pratima Sinha | |
| Suzanne Ostrand-Rosenberg | |||
| Lucas Horn | |||
| P2860 | cites work | Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein | Q24641894 |
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| Coordinated regulation of myeloid cells by tumours | Q28395157 | ||
| Subsets of myeloid-derived suppressor cells in tumor-bearing mice | Q29614297 | ||
| Immunosuppressive strategies that are mediated by tumor cells | Q29636247 | ||
| Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice | Q34813756 | ||
| GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells | Q34983887 | ||
| Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells | Q35052425 | ||
| L-arginine metabolism in myeloid cells controls T-lymphocyte functions. | Q35155944 | ||
| Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression | Q36259867 | ||
| Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma | Q36403544 | ||
| Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. | Q39770285 | ||
| Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity | Q40013431 | ||
| Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression | Q40338318 | ||
| Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. | Q40474320 | ||
| High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells | Q40519826 | ||
| Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. | Q40758963 | ||
| Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. | Q40836916 | ||
| TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma | Q42823116 | ||
| IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. | Q47883923 | ||
| Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. | Q54142377 | ||
| Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. | Q54421148 | ||
| Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 | ||
| Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine | Q60311223 | ||
| Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo | Q77620517 | ||
| Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells | Q80274418 | ||
| Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response | Q80582229 | ||
| CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells | Q81598364 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell function | Q95674809 |
| P304 | page(s) | 2052-2059 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα. | |
| P478 | volume | 42 |
| Q54265132 | Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation. |
| Q38294011 | CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) Cells: Rare Populations in the Human Decidua with Characteristics of MDSC. |
| Q35509317 | Complexity and challenges in defining myeloid-derived suppressor cells |
| Q42288675 | Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor models. |
| Q34484057 | Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors |
| Q38284706 | Dendritic cell defects in the colorectal cancer |
| Q40229629 | Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype |
| Q42149043 | HMGB1 promotes myeloid-derived suppressor cells and renal cell carcinoma immune escape |
| Q26863418 | Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer |
| Q34076238 | IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1. |
| Q42364557 | IFN-γ-STAT1-iNOS Induces Myeloid Progenitors to Acquire Immunosuppressive Activity |
| Q45936373 | Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. |
| Q38197617 | Interleukin-13 and its receptors in colorectal cancer (Review). |
| Q42840029 | Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells |
| Q64066398 | MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers |
| Q35681594 | Myeloid cells' evasion of melanoma immunity |
| Q33606107 | Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer |
| Q36767546 | Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2. |
| Q89976160 | Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer |
| Q26799126 | Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment |
| Q37200858 | Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis |
| Q91719323 | Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin |
| Q38118052 | Myeloid-derived suppressor cells in the inflammatory bowel diseases |
| Q34903354 | Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice |
| Q33816141 | Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal. |
| Q33842749 | Stat6 Promotes Intestinal Tumorigenesis in a Mouse Model of Adenomatous Polyposis by Expansion of MDSCs and Inhibition of Cytotoxic CD8 Response |
| Q37507187 | The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis |
| Q36322351 | Transcriptional regulation of myeloid-derived suppressor cells |
| Q39121591 | Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events |
| Q39445924 | Vemurafenib reverses immunosuppression by myeloid derived suppressor cells |
Search more.